| Dr Michael Johnson, MD | |
|
4424 Stanford St, Chevy Chase, MD 20815-5208 | |
| (202) 704-2914 | |
| Not Available |
| Full Name | Dr Michael Johnson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 4424 Stanford St, Chevy Chase, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700385812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | D0038828 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Johnson, MD 4424 Stanford St, Chevy Chase, MD 20815-5208 Ph: () - | Dr Michael Johnson, MD 4424 Stanford St, Chevy Chase, MD 20815-5208 Ph: (202) 704-2914 |
News Archive
The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve replacement (TAVR), found that the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority of the device for the primary hierarchical efficacy endpoint.
Numerous studies have documented IQ deficits in children with fetal alcohol syndrome (FAS). Little research, however, has found IQ deficits in children with alcohol-related neurodevelopmental disorder (ARND), who generally exhibit less severe neurobehavioral deficits than children with FAS.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.
Scientists at A*STAR's Genome Institute of Singapore, in collaboration with their counterparts from Canada, Hong Kong and US, have discovered a protein mediator SON plays a critical role in the health and proper functioning of human embryonic stem cells. This finding was reported on 8th September 2013 in the advanced online issue of the prestigious science journal Nature Cell Biology.
› Verified 4 days ago
Dr. Rachel Kaiser, MD, MPH Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5454 Wisconsin Ave, Suite 600, Chevy Chase, MD 20815 Phone: 301-942-7600 | |
Dr. Allen A. Nimetz, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5530 Wisconsin Ave, Suite 700, Chevy Chase, MD 20815 Phone: 301-656-5050 Fax: 301-654-4237 | |
Dr. Ankit B Shah, M.D., M.P.H. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8401 Connecticut Ave Ste 104, Chevy Chase, MD 20815 Phone: 240-892-7070 Fax: 240-248-0606 | |
Dr. Steve A Burka, MD Infectious Disease Medicare: May Accept Medicare Assignments Practice Location: 5530 Wisconsin Ave, #914, Chevy Chase, MD 20815 Phone: 301-654-3803 Fax: 301-654-3808 | |
Dr. Mark A Miller, Infectious Disease Medicare: Medicare Enrolled Practice Location: 4411 Leland St, Chevy Chase, MD 20815 Phone: 301-496-0815 | |
Dr. Sara Goldkind, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5630 Wisconsin Ave Apt 807, Chevy Chase, MD 20815 Phone: 240-353-0866 | |
Dr. Robert J Marshall, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5530 Wisconsin Ave Ste 700, Chevy Chase, MD 20815 Phone: 301-656-5050 Fax: 301-654-4237 |